Company information:
Vaxeal Immunotherapy Ltd (No: 10121388)
Address: 1ST FLOOR, CROMWELL HOUSE, 14 FULWOOD PLACE, LONDON, WC1V 6HZ, ENGLAND
Status: Active - Proposal to Strike off
Incorporated: 13-Apr-2016
Accounts Next Due: 31-Dec-2021
Next Confirmation Statement Due: 15-Jul-2022
Industry Class: 74990 - Non-trading company
Current Director: ROSEMARY DENISON ELLIS ( DOB: Apr-1965 From: May-2020 )
Current Director: CHRISTOPHER RICHARD SAMUELSON ( DOB: Jul-1946 From: Mar-2020 )
Resigned Director: JAMIE BANFILL ( DOB: May-1961 From: Mar-2020 To: Jun-2021 )
Resigned Director: AHMED BOUZIDI ( From: Jun-2016 To: Dec-2018 )
Resigned Director: MICHAEL DUKE ( DOB: Aug-1959 From: Apr-2016 To: Apr-2016 )
Resigned Director: ANTHONY NEVILLE CHISHOLM EASTMAN ( DOB: Nov-1974 From: Jun-2016 To: Dec-2022 )
Resigned Director: ALAN JOHN FRANK HITCHINS ( DOB: Apr-1947 From: Apr-2016 To: Dec-2022 )
Resigned Director: GEORGE PETER NICKLIN ( From: Jun-2016 To: Apr-2018 )
Resigned Secretary: GORRIE WHITSON SECRETARIAL SERVICES LIMITED ( From: May-2016 To: Dec-2022 )
Persons of Significant Control:
Vaxeal Holding Sa, 24 Avenue Paul-Ceresole, 1800 Vevey, Switzerland: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2017-04-06, Ceased: 2021-06-01)
Ms Rosemary Ellis, 1st Floor, Cromwell House 14 Fulwood Place, London, WC1V 6HZ, England: Ownership of shares – 75% or more (Notified: 2021-06-01)
Company Accounts Summary (£)
Item | 2017-04 | 2018-04 | 2019-03 | 2020-03 | Chart |
---|---|---|---|---|---|
Called up share capital not paid, not expressed as current asset | 1 | 1 | 1 | 1 | 1.0,1.0,1.0,1.0 |
Current assets | 183,053 | 183,053 | 183,053 | 183,053 | 183053.0,183053.0,183053.0,183053.0 |
Net current assets (liabilities) | 178,542 | 178,542 | 178,542 | 178,542 | 178542.0,178542.0,178542.0,178542.0 |
Total assets less current liabilities | 178,543 | 178,543 | 178,543 | 178,543 | 178543.0,178543.0,178543.0,178543.0 |
Net assets (liabilities) | 21,457 | 21,457 | 21,457 | 21,457 | 21457.0,21457.0,21457.0,21457.0 |
Equity / share capital and reserves | 21,457 | 21,457 | 21,457 | 21,457 | 21457.0,21457.0,21457.0,21457.0 |